Accueil › Cancer du sein › New Jersey › Newark
Essais cliniques pour Cancer du sein à Newark, NJ
18 études pour Cancer du sein recherchent des participants dans et autour de Newark (dans un rayon d'environ 30 miles). Ouvrez une étude pour voir qui peut participer et comment contacter l'équipe.
Texte officiel de l'étude (anglais)
Vous recrutez pour une étude ? Mettez-la en avant en haut de cette page — $99 pour 30 jours →
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
Recrutement en coursPhase 3
- Summit Health, Florham Park · à 12 mi
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Recrutement en coursÉtude observationnelleVolontaires sains bienvenus
- Morristown Medical Center, Morristown · à 17 mi
A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer
Recrutement en coursPhase 2
- Medical Oncology Hematology Associates, Newark
A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer
Recrutement en coursPhase 1/2
- Summit Medical Group, Florham Park · à 12 mi
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
Recrutement en coursPhase 3
- Rutgers Cancer Institute of NJ (Rutgers, The State University of New Jersey), Newark
- Rutgers Cancer Institute of NJ (Rutgers, The State University of New Jersey), Livingston · à 9 mi
- Summit Medical Group PA, Florham Park · à 12 mi
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
Recrutement en coursPhase 3
- Summit Medical Group, Florham Park · à 12 mi
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
Recrutement en coursPhase 3
- Summit Medical Group, Florham Park · à 12 mi
Evaluating Minimal Residual Disease (MRD) Through Longitudinal Circulating Tumor DNA (ctDNA) Profiling in Breast Malignancies
Recrutement en coursÉtude observationnelle
- Summit Medical Group, Florham Park · à 12 mi
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Recrutement en coursPhase 3
- Newark Beth Israel Medical Center, Newark
- Cooperman Barnabas Medical Center, Livingston · à 9 mi
- Morristown Medical Center, Morristown · à 17 mi
A Long-term Treatment Extension Study of Niraparib in Participants Who Completed a Prior GlaxoSmithKline/TESARO-sponsored Niraparib Study
Recrutement en coursPhase 2
- GSK Investigational Site, Morristown · à 17 mi
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Recrutement en coursPhase 3
- Morristown Medical Center, Morristown · à 17 mi
SDM POSSIBLE: A Breast Cancer Treatment Decision Aid for Women 70+ With Low-Risk Stage I Breast Cancers
Recrutement en cours
- Rutgers State University of New Jersey Medical School, Newark
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Recrutement en coursÉtude observationnelle
- Morristown Medical Center, Morristown · à 17 mi
Confirmatory Clinical Evaluation of Novilase® Laser Therapy for Focal Destruction of Malignant Breast Tumors
Recrutement en cours
- Summit Health, Florham Park · à 12 mi
RADIANT: Pre-op Radiation With Abemaciclib and Letrozole
Recrutement en coursPhase 1
- RWJBarnabas Health Clara Maas Medical Center, Belleville · à 4 mi
- Cooperman Barnabas Medical Center, Livingston · à 9 mi
Statins for Reduction of Cardiac Toxicity in Patients Receiving HER2 Targeted
Recrutement en coursPhase 2
- RWJBarnabas Health - Newark Beth Israel Medical Center, Newark
DPYD Pharmacogenomics and Fluoropyrimidine (FP) Dose-Adjustment
Recrutement en coursPhase 4
- Cancer Center Initiative, Newark
- University Hospital, Newark
- RWJBarnabas Health Newark Beth Israel Medical Center, Newark
- et 2 autres
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
Recrutement en coursPhase 3
- Morristown Medical Center, Morristown · à 17 mi
Essais pour Cancer du sein dans d'autres villes
- New York City, NY136 études
- Houston, TX126 études
- Boston, MA112 études
- Nashville, TN81 études
- Los Angeles, CA73 études
- Edison, NJ68 études
- St. Louis, MO64 études
- Queens, NY64 études
- Durham, NC64 études
- Chicago, IL59 études
- Philadelphia, PA56 études
- Dallas, TX55 études
Autres études à Newark
- Lésions de la moelle épinière13 études
- Cancer du poumon non à petites cellules13 études
- Leucémie aiguë myéloïde12 études
- Insuffisance cardiaque10 études
- Cancer métastatique10 études
- Maladie cardiovasculaire9 études
- Cancer du pancréas9 études
- Mélanome8 études
- Cancer (tous types)7 études
- Cancer du poumon7 études
- Maladie de Crohn7 études
- Sténose de la valve aortique6 études
Source : ClinicalTrials.gov, données récupérées le 6 oct. 2026. Chaque étude définit ses propres critères d'éligibilité ; l'équipe de l'étude décide qui peut y participer.